OB/GYN Clinical Alert – October 1, 2010
October 1, 2010
View Issues
-
Low-dose Aspirin to Prevent Preeclampsia
Many clinicians are reluctant to give low-dose aspirin (ldasa) to pregnant women for the prevention of preeclampsia. This reluctance is not based on a fear of potential risk, but on inconsistent study results regarding the efficacy of ASA. -
Intravenous Immunoglobin and Recurrent Miscarriage
Secondary recurrent miscarriage (defined as three or more pregnancy losses at < 20 weeks occurring in a women with a least one pregnancy carried beyond 20 weeks) may be explained by a chromosomal abnormality or be "unexplained" (idiopathic). -
New Biological Agents for the Treatment of Cervical Cancer
Previous investigation of cervical cancer biology has revealed a dependence on VEGF, among other factors, for growth and metastases. -
Microbicides Are Back!
The "Caprisa 004" trial was a randomized double-blind controlled trial of 1085 sexually active, HIV-negative, high-risk women in South Africa over 2.5 years (889 women were included in the final analysis). -
In Search of Adhesion-free Pelvic Surgery
The author summarizes the protocols used at his institution to prevent adhesions in patients who were undergoing evaluation and treatment for significant pelvic pathology. -
Pharmacology Watch: Antiviral Medications Not Associated with Birth Defects
In this issue: Antiviral drugs and birth defects, bisphosphonates and esophageal cancer, naltrexone plus bupropion for weight loss, 2010-11 influenza vaccine, FDA Actions. -
Clinical Briefs in Primary Care supplement